Reactions to Disease Risk Information

Sponsor
National Human Genome Research Institute (NHGRI) (NIH)
Overall Status
Completed
CT.gov ID
NCT00774254
Collaborator
(none)
132
1
1
15.5
8.5

Study Details

Study Description

Brief Summary

This study is part of an effort to learn about interactions between doctors and patients. The study will use virtual reality technology to examine how patients and doctors interact when they discuss disease risks.

Men and women between the ages of 25 and 40 who have access to the Internet and were born and raised in the United States may be eligible for this study. Participants will be recruited from the Washington D.C. area.

Participants undergo the following procedures:
  • Complete an online questionnaire about their health-related background, family health history, cancer risk perceptions, and demographic information (e.g., age, marital status, education, etc.).

  • Participate in activities in a virtual reality environment in which they interact with a virtual doctor in a virtual clinical scenario. For this experiment, participants wear a head-mounted display that allows them to see the virtual world images.

  • Fill out a second questionnaire after completing the virtual reality activities. This questionnaire includes information on the participants virtual reality experience, the information provided in the experience, and questions about themselves and their background.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: A
  • Behavioral: B
N/A

Detailed Description

This study will investigate interactions between doctors and patients regarding risks of common, complex diseases using virtual reality technology.

Men and women between the ages of 25 and 40 who have access to the Internet and were born and raised in the United States may be eligible for this study. Participants will be recruited from the Washington D.C. area.

Study subjects complete two phases. The first phase is to complete an online questionnaire about their heath-related background, family health history, cancer risk perceptions, and demographic information using a secure survey website. The second phase involves interacting with a virtual doctor in a virtual environment clinical scenario, followed by completion of a second questionnaire. While in the virtual environment, participants wear a head-mounted video unit that allows them to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.

Study Design

Study Type:
Interventional
Actual Enrollment :
132 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
Participant Reactions to Disease Risk Information
Actual Study Start Date :
Jun 16, 2009
Actual Primary Completion Date :
Sep 30, 2010
Actual Study Completion Date :
Sep 30, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

Behavioral: A
Intervention

Behavioral: B
Intervention

Outcome Measures

Primary Outcome Measures

  1. Risk Perception [ongoing]

    The objective of the proposed study is to examine a cognitive bias known as anchoring and adjustment that may occur during provider-patient interactions, such as during provision of risk information for common, complex diseases that have both genetic and behavioralcomponents.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
  • INCLUSION CRITERIA:

  • Self-reported ability to speak, read, and write in English.

  • Self identifying as African-American or Black

  • Having been born and raised in the U.S.

  • Not having been diagnosed with any of the diseases used in the experiment.

  • Being between 25 and 40 years of age.

  • Having access to the Internet.

  • Both men and women will be included in the study.

EXCLUSION CRITERIA:
  • Individuals below the age of 25 because they might not yet have completed their education and those above the age of 40 because they might have less familiarity with interactive technologies than younger individuals.

  • Because the study will utilize virtual reality technology, individuals who are particularly susceptible to motion sickness will be excluded.

  • All individuals with epilepsy, low vision, hearing problems, and vestibular disorders (e.g., vertigo) will be excluded from the study for safety reasons.

  • We will re-screen for safety exclusion criteria when participants arrive to participate in the in-person portion of the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland United States 20892

Sponsors and Collaborators

  • National Human Genome Research Institute (NHGRI)

Investigators

  • Principal Investigator: Susan Persky, Ph.D., National Human Genome Research Institute (NHGRI)

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
National Human Genome Research Institute (NHGRI)
ClinicalTrials.gov Identifier:
NCT00774254
Other Study ID Numbers:
  • 090009
  • 09-HG-0009
First Posted:
Oct 17, 2008
Last Update Posted:
Aug 4, 2022
Last Verified:
Dec 17, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Human Genome Research Institute (NHGRI)

Study Results

No Results Posted as of Aug 4, 2022